Talphera, Inc.

General ticker "TLPH" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $54.4M (TTM average)

Talphera, Inc. follows the US Stock Market performance with the rate: 29.6%.

Estimated limits based on current volatility of 7.8%: low 0.74$, high 0.86$

Factors to consider:

  • Total employees count: 12 (-7.7%) as of 2025
  • Top business risk factors: Capital constraints, Regulatory and compliance, Clinical trial failure, Labor/talent shortage/retention, Supply chain disruptions
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [0.63$, 1.79$]
  • 2026-12-31 to 2027-12-31 estimated range: [0.44$, 1.31$]

Financial Metrics affecting the TLPH estimates:

  • Positive: with PPE of -3.0 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -0.61 <= 0.01
  • Negative: Investing cash flow per share per price, % of -30.75 <= -18.01
  • Negative: 49.34 < Shareholder equity ratio, % of 57.32 <= 58.04

Similar symbols

Short-term TLPH quotes

Long-term TLPH plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.65MM $0.00MM $0.03MM
Operating Expenses $17.54MM $15.25MM $13.51MM
Operating Income $-16.89MM $-15.25MM $-13.48MM
Non-Operating Income $6.60MM $2.25MM $-0.88MM
Interest Expense $0.13MM $0.00MM $0.00MM
R&D Expense $5.55MM $6.72MM $6.03MM
Income(Loss) $-10.29MM $-13.00MM $-14.36MM
Other Income(Loss) $-8.11MM $0.00MM $0.07MM
Net Income(Loss)* $-18.40MM $-13.00MM $-14.29MM
Stockholders Equity $14.11MM $8.00MM $17.04MM
Assets $20.39MM $18.24MM $29.72MM
Operating Cash Flow $-17.49MM $-12.68MM $-11.36MM
Capital expenditure $0.10MM $0.00MM $0.00MM
Investing Cash Flow $-0.53MM $3.78MM $-14.35MM
Financing Cash Flow $3.47MM $12.04MM $22.74MM
Earnings Per Share** $-1.29 $-0.50 $-0.34

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.